Rui Ge

2.1k total citations
87 papers, 1.6k citations indexed

About

Rui Ge is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Rui Ge has authored 87 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 22 papers in Oncology and 19 papers in Immunology. Recurrent topics in Rui Ge's work include HER2/EGFR in Cancer Research (8 papers), Advanced Breast Cancer Therapies (6 papers) and Organometallic Compounds Synthesis and Characterization (6 papers). Rui Ge is often cited by papers focused on HER2/EGFR in Cancer Research (8 papers), Advanced Breast Cancer Therapies (6 papers) and Organometallic Compounds Synthesis and Characterization (6 papers). Rui Ge collaborates with scholars based in China, United States and Belgium. Rui Ge's co-authors include Qingshan Li, Gang Wang, Tianwen Gao, Chunying Li, Wei Dai, Jiankuan Li, Li Tang, Sen Guo, Qiong Shi and Zhe Jian and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Development.

In The Last Decade

Rui Ge

84 papers receiving 1.6k citations

Peers

Countries citing papers authored by Rui Ge

Since Specialization

Citations

This map shows the geographic impact of Rui Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Ge more than expected).

Fields of papers citing papers by Rui Ge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Ge. The network helps show where Rui Ge may publish in the future.

Co-authorship network of co-authors of Rui Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Ge. A scholar is included among the top collaborators of Rui Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Ge. Rui Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dulcitol ameliorates LPS-induced acute lung injury (ALI) in mice by inhibiting TLR4/NF-κB activation 2025 ·Journal of Functional Foods ·Rui Ge, Qian Peter Su, Jian Liang, Lu Zheng, Qing‐Shan Li, Li Tang	1
2	Crucial roles of asprosin in cisplatin-induced ferroptosis and acute kidney injury 2024 ·Free Radical Biology and Medicine ·(unknown), (unknown), (unknown), Xiaoyu Xu, Bing Zhou, Rui Ge, Min Dai, Hongbiao Dong, (unknown), (unknown), Guo‐Qing Zhu, Ye‐Bo Zhou	2
3	Promotion of nerve regeneration and motor function recovery in SCI rats using LOCAS-iPSCs-NSCs 2024 ·Stem Cell Research & Therapy ·Gang Xu, Rui Ge, Chunli Zhang, (unknown), (unknown), (unknown), (unknown), Jing Zhang, Yantao Zhao, Shuxun Hou, Li Li, Peng George Wang	3
4	Asprosin promotes vascular inflammation via TLR4-NFκB-mediated NLRP3 inflammasome activation in hypertension 2024 ·Heliyon ·Rui Ge, (unknown), (unknown), (unknown), Min Dai, (unknown), (unknown), (unknown), (unknown), (unknown)	7
5	Changes in the epidemiological burden of melanoma in China from 1990 to 2019 based on the Global Burden of Disease 2024 ·Chinese Medical Journal ·(unknown), (unknown), (unknown), Rui Ge, Jian Zhang	1
6	Multisystem Langerhans Cell Histiocytosis in Younger Infants First Presenting in Skin: A Case Series 2022 ·Journal of Personalized Medicine ·Dan Han, (unknown), (unknown), Rui Ge, Yan Zhao, (unknown), (unknown), (unknown)	2
7	PARP1 Is a Prognostic Marker and Targets NFATc2 to Promote Carcinogenesis in Melanoma 2022 ·Genetic Testing and Molecular Biomarkers ·Kuanhou Mou, Yan Zhou, Xin Mu, Jian Zhang, Lijuan Wang, Rui Ge	2
8	Application of Gross Tissue Response System in Gastric Cancer After Neoadjuvant Chemotherapy: A Primary Report of a Prospective Cohort Study 2021 ·Frontiers in Oncology ·Hua Yang, Weihan Zhang, Rui Ge, (unknown), Xin‐Zu Chen, Kun Yang, Kai Liu, Xiao‐Long Chen, Du He, Jianping Liu, Weiwei Zhang, Yun Qin, Zong‐Guang Zhou, Jian-Kun Hu	4
9	[Expert consensus on the management of adverse events of ErbB family tyrosine kinase inhibitors in breast cancer]. 2020 ·PubMed ·(unknown), Rui Ge, Zefei Jiang	4
10	Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study 2020 ·Frontiers in Oncology ·Yi Li, Chengcheng Gong, Qianyi Lu, (unknown), Ting Luo, Wei Li, Gang Li, Rui Ge, Fei Xu, Biyun Wang	10
11	Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR‑367/PTEN axis 2019 ·International Journal of Oncology ·Xin Mu, Kuanhou Mou, Rui Ge, Dan Han, Yan Zhou, Lijuan Wang	20
12	Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study 2019 ·Clinical Breast Cancer ·Yizhao Xie, Yi Li, Yinbin Zhang, Shuqun Zhang, Wěi Li, Xiaoxiang Guan, Yannan Zhao, Chengcheng Gong, Xichun Hu, Jiän Zhang, (unknown), Leiping Wang, Rui Ge, Biyun Wang	4
13	Synthesis and cytotoxic activities of novel 4-methoxy-substituted and 5-methyl-substituted (3′<em>S</em>,4′<em>S</em>)-(-)-<em>cis</em>-khellactone derivatives that induce apoptosis via the intrinsic pathway 2017 ·Drug Design Development and Therapy ·Jingrun Chen, Junjie Liu, Dongxiao Cui, (unknown), Liqiang Meng, Liqian Sun, Shurong Ban, Rui Ge, Taigang Liang, Qingshan Li	3
14	Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1 2016 ·Journal of Investigative Dermatology ·Rui Ge, Lin Liu, Wei Dai, Weigang Zhang, Yuqi Yang, Huina Wang, Qiong Shi, Sen Guo, Xiuli Yi, Gang Wang, Tianwen Gao, Qi Luan, Chunying Li	29
15	Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis 2016 ·Journal of Investigative Dermatology ·Sen Guo, Weinan Guo, Shuli Li, Wei Dai, Nan Zhang, Tao Zhao, Huina Wang, Jingjing Ma, Xiuli Yi, Rui Ge, Gang Wang, Tianwen Gao, Chunying Li	43
16	652 XPA promotes autophagy to facilitate cisplatin resistance in melanoma cells through the activation of PARP1 2016 ·Journal of Investigative Dermatology ·Rui Ge, L. Liu, Wei Dai, Wenli Zhang, Yang Yue, H. Wang, Qiong Shi, Shuo Guo, Xiuli Yi, Gang Wang, Tianwen Gao, Qi Luan, (unknown)	5
17	Oxidative stress-induced overexpression of miR-25: the mechanism underlying the degeneration of melanocytes in vitiligo 2015 ·Cell Death and Differentiation ·Qiong Shi, (unknown), (unknown), Zhe Jian, (unknown), Ke-Jin Li, Rui Ge, Wei Dai, Gang Wang, Tianwen Gao, Chunying Li	94
18	Oxidative stress in di-n-butyl-di-(4-chlorobenzohydroxamato)tin (IV)-induced hepatotoxicity determined by proteomic profiles 2012 ·Toxicology Letters ·Li Tang, Yun‐Lan Li, Rui Ge, Qingshan Li	8
19	Association of KIR genotype with susceptibility to HLA-B27-positive ankylosing spondylitis 2012 ·Modern Rheumatology ·Sheng Wang, (unknown), Rui Ge, Zhenhua Duan, (unknown), Tianchen Zhang, Jing Gao, Ting Yang, (unknown), Shanshan Wu, Dazhi Fan, Shengqian Xu, Jianhua Xu, Li Zhang, Zongwen Shuai, Dong‐Qing Ye, Yanfeng Zou, Faming Pan	15
20	Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis 2010 ·Clinical Rheumatology ·Mei Yang, Faming Pan, Jing Gao, Rui Ge, Zhenhua Duan, Zhen Zeng, Fangfang Liao, Guo Xia, Sheng Wang, Shengqian Xu, Jianhua Xu, Li Zhang, Dong‐Qing Ye	188

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact